Rhonda Lightle Selected Research

Cavernous Hemangioma (Cavernous Angioma)

11/2021	Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage.
1/2021	A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
1/2020	A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease.
1/2019	Biomarkers of cavernous angioma with symptomatic hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rhonda Lightle Research Topics

Disease

11	Central Nervous System Cavernous Hemangioma 01/2022 - 01/2016
9	Hemorrhage 01/2022 - 01/2017
4	Cavernous Hemangioma (Cavernous Angioma) 11/2021 - 01/2019
3	Vascular Malformations 10/2021 - 01/2016
1	Familial cerebral cavernous malformation 06/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Disease Progression 01/2018
1	Inflammation (Inflammations) 01/2018
1	Stroke (Strokes) 01/2017

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	IronIBA 01/2021 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2020
3	Propranolol (Inderal)FDA LinkGeneric 01/2022 - 01/2021
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2017
3	rho-Associated KinasesIBA 01/2020 - 01/2016
2	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2019
2	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2021 - 01/2021
2	fasudil (AT 877)IBA 01/2019 - 01/2017
2	Simvastatin (Zocor)FDA LinkGeneric 01/2019 - 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Lipopolysaccharide ReceptorsIBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2021
1	Pharmaceutical PreparationsIBA 11/2020
1	LipopolysaccharidesIBA 11/2020
1	Transcription Factors (Transcription Factor)IBA 10/2020
1	Versicans (Versican)IBA 10/2020
1	AntibodiesIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	AutoantigensIBA 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	Protein Kinase InhibitorsIBA 01/2019
1	Heme (Haem)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2016
1	Aftercare (After-Treatment) 01/2020